1 Market Overview

1.1 Product Overview and Scope of Covid-19 Vaccine

1.2 Classification of Covid-19 Vaccine by Type

1.2.1 Overview: Global Covid-19 Vaccine Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Covid-19 Vaccine Revenue Market Share by Type in 2020

1.2.3 DNA

1.2.4 Live Attenuated Virus

1.2.5 NonReplicating Viral Vecto

1.2.6 Protein Subunit

1.2.7 RNA

1.3 Global Covid-19 Vaccine Market by Application

1.3.1 Overview: Global Covid-19 Vaccine Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Treatment

1.3.3 Prevention

1.4 Global Covid-19 Vaccine Market Size & Forecast

1.5 Global Covid-19 Vaccine Market Size and Forecast by Region

1.5.1 Global Covid-19 Vaccine Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Covid-19 Vaccine Market Size by Region, (2016-2021)

1.5.3 North America Covid-19 Vaccine Market Size and Prospect (2016-2026)

1.5.4 Europe Covid-19 Vaccine Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Covid-19 Vaccine Market Size and Prospect (2016-2026)

1.5.6 South America Covid-19 Vaccine Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Covid-19 Vaccine Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Covid-19 Vaccine Market Drivers

1.6.2 Covid-19 Vaccine Market Restraints

1.6.3 Covid-19 Vaccine Trends Analysis

2 Company Profiles

2.1 Inovio Pharmaceuticals

2.1.1 Inovio Pharmaceuticals Details

2.1.2 Inovio Pharmaceuticals Major Business

2.1.3 Inovio Pharmaceuticals Covid-19 Vaccine Product and Solutions

2.1.4 Inovio Pharmaceuticals Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Inovio Pharmaceuticals Recent Developments and Future Plans

2.2 Takis Biotech (Evvivax)

2.2.1 Takis Biotech (Evvivax) Details

2.2.2 Takis Biotech (Evvivax) Major Business

2.2.3 Takis Biotech (Evvivax) Covid-19 Vaccine Product and Solutions

2.2.4 Takis Biotech (Evvivax) Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Takis Biotech (Evvivax) Recent Developments and Future Plans

2.3 Zydus Cadila

2.3.1 Zydus Cadila Details

2.3.2 Zydus Cadila Major Business

2.3.3 Zydus Cadila Covid-19 Vaccine Product and Solutions

2.3.4 Zydus Cadila Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Zydus Cadila Recent Developments and Future Plans

2.4 Codagenix, Inc.

2.4.1 Codagenix, Inc. Details

2.4.2 Codagenix, Inc. Major Business

2.4.3 Codagenix, Inc. Covid-19 Vaccine Product and Solutions

2.4.4 Codagenix, Inc. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Codagenix, Inc. Recent Developments and Future Plans

2.5 GeoVax, Inc.

2.5.1 GeoVax, Inc. Details

2.5.2 GeoVax, Inc. Major Business

2.5.3 GeoVax, Inc. Covid-19 Vaccine Product and Solutions

2.5.4 GeoVax, Inc. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 GeoVax, Inc. Recent Developments and Future Plans

2.6 Bravovax

2.6.1 Bravovax Details

2.6.2 Bravovax Major Business

2.6.3 Bravovax Covid-19 Vaccine Product and Solutions

2.6.4 Bravovax Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Bravovax Recent Developments and Future Plans

2.7 Janssen Pharmaceutical Companies

2.7.1 Janssen Pharmaceutical Companies Details

2.7.2 Janssen Pharmaceutical Companies Major Business

2.7.3 Janssen Pharmaceutical Companies Covid-19 Vaccine Product and Solutions

2.7.4 Janssen Pharmaceutical Companies Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Janssen Pharmaceutical Companies Recent Developments and Future Plans

2.8 Altimmune

2.8.1 Altimmune Details

2.8.2 Altimmune Major Business

2.8.3 Altimmune Covid-19 Vaccine Product and Solutions

2.8.4 Altimmune Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Altimmune Recent Developments and Future Plans

2.9 Vaxart

2.9.1 Vaxart Details

2.9.2 Vaxart Major Business

2.9.3 Vaxart Covid-19 Vaccine Product and Solutions

2.9.4 Vaxart Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Vaxart Recent Developments and Future Plans

2.10 CanSino Biologics

2.10.1 CanSino Biologics Details

2.10.2 CanSino Biologics Major Business

2.10.3 CanSino Biologics Covid-19 Vaccine Product and Solutions

2.10.4 CanSino Biologics Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 CanSino Biologics Recent Developments and Future Plans

2.11 ExpreS2ion Biotechnologies ApS

2.11.1 ExpreS2ion Biotechnologies ApS Details

2.11.2 ExpreS2ion Biotechnologies ApS Major Business

2.11.3 ExpreS2ion Biotechnologies ApS Covid-19 Vaccine Product and Solutions

2.11.4 ExpreS2ion Biotechnologies ApS Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 ExpreS2ion Biotechnologies ApS Recent Developments and Future Plans

2.12 Clover Biopharmaceuticals

2.12.1 Clover Biopharmaceuticals Details

2.12.2 Clover Biopharmaceuticals Major Business

2.12.3 Clover Biopharmaceuticals Covid-19 Vaccine Product and Solutions

2.12.4 Clover Biopharmaceuticals Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Clover Biopharmaceuticals Recent Developments and Future Plans

2.13 GSK

2.13.1 GSK Details

2.13.2 GSK Major Business

2.13.3 GSK Covid-19 Vaccine Product and Solutions

2.13.4 GSK Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 GSK Recent Developments and Future Plans

2.14 Vaxil Bio Ltd.

2.14.1 Vaxil Bio Ltd. Details

2.14.2 Vaxil Bio Ltd. Major Business

2.14.3 Vaxil Bio Ltd. Covid-19 Vaccine Product and Solutions

2.14.4 Vaxil Bio Ltd. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Vaxil Bio Ltd. Recent Developments and Future Plans

2.15 Generex

2.15.1 Generex Details

2.15.2 Generex Major Business

2.15.3 Generex Covid-19 Vaccine Product and Solutions

2.15.4 Generex Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Generex Recent Developments and Future Plans

2.16 Novavax, Inc.

2.16.1 Novavax, Inc. Details

2.16.2 Novavax, Inc. Major Business

2.16.3 Novavax, Inc. Covid-19 Vaccine Product and Solutions

2.16.4 Novavax, Inc. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Novavax, Inc. Recent Developments and Future Plans

2.17 Sanofi Pasteur

2.17.1 Sanofi Pasteur Details

2.17.2 Sanofi Pasteur Major Business

2.17.3 Sanofi Pasteur Covid-19 Vaccine Product and Solutions

2.17.4 Sanofi Pasteur Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Sanofi Pasteur Recent Developments and Future Plans

2.18 Baylor

2.18.1 Baylor Details

2.18.2 Baylor Major Business

2.18.3 Baylor Covid-19 Vaccine Product and Solutions

2.18.4 Baylor Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Baylor Recent Developments and Future Plans

2.19 iBio, Inc.

2.19.1 iBio, Inc. Details

2.19.2 iBio, Inc. Major Business

2.19.3 iBio, Inc. Covid-19 Vaccine Product and Solutions

2.19.4 iBio, Inc. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 iBio, Inc. Recent Developments and Future Plans

2.20 Zydus Cadila

2.20.1 Zydus Cadila Details

2.20.2 Zydus Cadila Major Business

2.20.3 Zydus Cadila Covid-19 Vaccine Product and Solutions

2.20.4 Zydus Cadila Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 Zydus Cadila Recent Developments and Future Plans

2.21 Moderna, Inc.

2.21.1 Moderna, Inc. Details

2.21.2 Moderna, Inc. Major Business

2.21.3 Moderna, Inc. Covid-19 Vaccine Product and Solutions

2.21.4 Moderna, Inc. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2021)

2.21.5 Moderna, Inc. Recent Developments and Future Plans

2.22 Curevac

2.22.1 Curevac Details

2.22.2 Curevac Major Business

2.22.3 Curevac Covid-19 Vaccine Product and Solutions

2.22.4 Curevac Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2021)

2.22.5 Curevac Recent Developments and Future Plans

2.23 ImmunoPrecise

2.23.1 ImmunoPrecise Details

2.23.2 ImmunoPrecise Major Business

2.23.3 ImmunoPrecise Covid-19 Vaccine Product and Solutions

2.23.4 ImmunoPrecise Covid-19 Vaccine Revenue, Gross Margin and Market Share (2019-2021)

2.23.5 ImmunoPrecise Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Covid-19 Vaccine Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Covid-19 Vaccine Players Market Share

3.2.2 Top 10 Covid-19 Vaccine Players Market Share

3.2.3 Market Competition Trend

3.3 Covid-19 Vaccine Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Covid-19 Vaccine Revenue and Market Share by Type (2016-2021)

4.2 Global Covid-19 Vaccine Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Covid-19 Vaccine Revenue Market Share by Application (2016-2021)

5.2 Covid-19 Vaccine Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Covid-19 Vaccine Revenue by Type (2016-2026)

6.2 North America Covid-19 Vaccine Revenue by Application (2016-2026)

6.3 North America Covid-19 Vaccine Market Size by Country

6.3.1 North America Covid-19 Vaccine Revenue by Country (2016-2026)

6.3.2 United States Covid-19 Vaccine Market Size and Forecast (2016-2026)

6.3.3 Canada Covid-19 Vaccine Market Size and Forecast (2016-2026)

6.3.4 Mexico Covid-19 Vaccine Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Covid-19 Vaccine Revenue by Type (2016-2026)

7.2 Europe Covid-19 Vaccine Revenue by Application (2016-2026)

7.3 Europe Covid-19 Vaccine Market Size by Country

7.3.1 Europe Covid-19 Vaccine Revenue by Country (2016-2026)

7.3.2 Germany Covid-19 Vaccine Market Size and Forecast (2016-2026)

7.3.3 France Covid-19 Vaccine Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Covid-19 Vaccine Market Size and Forecast (2016-2026)

7.3.5 Russia Covid-19 Vaccine Market Size and Forecast (2016-2026)

7.3.6 Italy Covid-19 Vaccine Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Covid-19 Vaccine Revenue by Type (2016-2026)

8.2 Asia-Pacific Covid-19 Vaccine Revenue by Application (2016-2026)

8.3 Asia-Pacific Covid-19 Vaccine Market Size by Region

8.3.1 Asia-Pacific Covid-19 Vaccine Revenue by Region (2016-2026)

8.3.2 China Covid-19 Vaccine Market Size and Forecast (2016-2026)

8.3.3 Japan Covid-19 Vaccine Market Size and Forecast (2016-2026)

8.3.4 South Korea Covid-19 Vaccine Market Size and Forecast (2016-2026)

8.3.5 India Covid-19 Vaccine Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Covid-19 Vaccine Market Size and Forecast (2016-2026)

8.3.7 Australia Covid-19 Vaccine Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Covid-19 Vaccine Revenue by Type (2016-2026)

9.2 South America Covid-19 Vaccine Revenue by Application (2016-2026)

9.3 South America Covid-19 Vaccine Market Size by Country

9.3.1 South America Covid-19 Vaccine Revenue by Country (2016-2026)

9.3.2 Brazil Covid-19 Vaccine Market Size and Forecast (2016-2026)

9.3.3 Argentina Covid-19 Vaccine Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Covid-19 Vaccine Revenue by Type (2016-2026)

10.2 Middle East & Africa Covid-19 Vaccine Revenue by Application (2016-2026)

10.3 Middle East & Africa Covid-19 Vaccine Market Size by Country

10.3.1 Middle East & Africa Covid-19 Vaccine Revenue by Country (2016-2026)

10.3.2 Turkey Covid-19 Vaccine Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Covid-19 Vaccine Market Size and Forecast (2016-2026)

10.3.4 UAE Covid-19 Vaccine Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Covid-19 Vaccine Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Covid-19 Vaccine Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Covid-19 Vaccine Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Covid-19 Vaccine Revenue (USD Million) by Region (2016-2021)

Table 5. Global Covid-19 Vaccine Revenue Market Share by Region (2021-2026)

Table 6. Inovio Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 7. Inovio Pharmaceuticals Major Business

Table 8. Inovio Pharmaceuticals Covid-19 Vaccine Product and Solutions

Table 9. Inovio Pharmaceuticals Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Takis Biotech (Evvivax) Corporate Information, Head Office, and Major Competitors

Table 11. Takis Biotech (Evvivax) Major Business

Table 12. Takis Biotech (Evvivax) Covid-19 Vaccine Product and Solutions

Table 13. Takis Biotech (Evvivax) Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Zydus Cadila Corporate Information, Head Office, and Major Competitors

Table 15. Zydus Cadila Major Business

Table 16. Zydus Cadila Covid-19 Vaccine Product and Solutions

Table 17. Zydus Cadila Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Codagenix, Inc. Corporate Information, Head Office, and Major Competitors

Table 19. Codagenix, Inc. Major Business

Table 20. Codagenix, Inc. Covid-19 Vaccine Product and Solutions

Table 21. Codagenix, Inc. Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. GeoVax, Inc. Corporate Information, Head Office, and Major Competitors

Table 23. GeoVax, Inc. Major Business

Table 24. GeoVax, Inc. Covid-19 Vaccine Product and Solutions

Table 25. GeoVax, Inc. Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Bravovax Corporate Information, Head Office, and Major Competitors

Table 27. Bravovax Major Business

Table 28. Bravovax Covid-19 Vaccine Product and Solutions

Table 29. Bravovax Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Janssen Pharmaceutical Companies Corporate Information, Head Office, and Major Competitors

Table 31. Janssen Pharmaceutical Companies Major Business

Table 32. Janssen Pharmaceutical Companies Covid-19 Vaccine Product and Solutions

Table 33. Janssen Pharmaceutical Companies Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Altimmune Corporate Information, Head Office, and Major Competitors

Table 35. Altimmune Major Business

Table 36. Altimmune Covid-19 Vaccine Product and Solutions

Table 37. Altimmune Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Vaxart Corporate Information, Head Office, and Major Competitors

Table 39. Vaxart Major Business

Table 40. Vaxart Covid-19 Vaccine Product and Solutions

Table 41. Vaxart Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. CanSino Biologics Corporate Information, Head Office, and Major Competitors

Table 43. CanSino Biologics Major Business

Table 44. CanSino Biologics Covid-19 Vaccine Product and Solutions

Table 45. CanSino Biologics Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. ExpreS2ion Biotechnologies ApS Corporate Information, Head Office, and Major Competitors

Table 47. ExpreS2ion Biotechnologies ApS Major Business

Table 48. ExpreS2ion Biotechnologies ApS Covid-19 Vaccine Product and Solutions

Table 49. ExpreS2ion Biotechnologies ApS Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Clover Biopharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 51. Clover Biopharmaceuticals Major Business

Table 52. Clover Biopharmaceuticals Covid-19 Vaccine Product and Solutions

Table 53. Clover Biopharmaceuticals Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. GSK Corporate Information, Head Office, and Major Competitors

Table 55. GSK Major Business

Table 56. GSK Covid-19 Vaccine Product and Solutions

Table 57. GSK Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Vaxil Bio Ltd. Corporate Information, Head Office, and Major Competitors

Table 59. Vaxil Bio Ltd. Major Business

Table 60. Vaxil Bio Ltd. Covid-19 Vaccine Product and Solutions

Table 61. Vaxil Bio Ltd. Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Generex Corporate Information, Head Office, and Major Competitors

Table 63. Generex Major Business

Table 64. Generex Covid-19 Vaccine Product and Solutions

Table 65. Generex Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Novavax, Inc. Corporate Information, Head Office, and Major Competitors

Table 67. Novavax, Inc. Major Business

Table 68. Novavax, Inc. Covid-19 Vaccine Product and Solutions

Table 69. Novavax, Inc. Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Sanofi Pasteur Corporate Information, Head Office, and Major Competitors

Table 71. Sanofi Pasteur Major Business

Table 72. Sanofi Pasteur Covid-19 Vaccine Product and Solutions

Table 73. Sanofi Pasteur Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Baylor Corporate Information, Head Office, and Major Competitors

Table 75. Baylor Major Business

Table 76. Baylor Covid-19 Vaccine Product and Solutions

Table 77. Baylor Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. iBio, Inc. Corporate Information, Head Office, and Major Competitors

Table 79. iBio, Inc. Major Business

Table 80. iBio, Inc. Covid-19 Vaccine Product and Solutions

Table 81. iBio, Inc. Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. Zydus Cadila Corporate Information, Head Office, and Major Competitors

Table 83. Zydus Cadila Major Business

Table 84. Zydus Cadila Covid-19 Vaccine Product and Solutions

Table 85. Zydus Cadila Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. Moderna, Inc. Corporate Information, Head Office, and Major Competitors

Table 87. Moderna, Inc. Major Business

Table 88. Moderna, Inc. Covid-19 Vaccine Product and Solutions

Table 89. Moderna, Inc. Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 90. Curevac Corporate Information, Head Office, and Major Competitors

Table 91. Curevac Major Business

Table 92. Curevac Covid-19 Vaccine Product and Solutions

Table 93. Curevac Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 94. ImmunoPrecise Corporate Information, Head Office, and Major Competitors

Table 95. ImmunoPrecise Major Business

Table 96. ImmunoPrecise Covid-19 Vaccine Product and Solutions

Table 97. ImmunoPrecise Covid-19 Vaccine Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 98. Global Covid-19 Vaccine Revenue (USD Million) by Players (2019-2021)

Table 99. Global Covid-19 Vaccine Revenue Share by Players (2019-2021)

Table 100. Breakdown of Covid-19 Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)

Table 101. Covid-19 Vaccine Players Head Office, Products and Services Provided

Table 102. Covid-19 Vaccine Mergers & Acquisitions in the Past Five Years

Table 103. Covid-19 Vaccine New Entrants and Expansion Plans

Table 104. Global Covid-19 Vaccine Revenue (USD Million) by Type (2016-2021)

Table 105. Global Covid-19 Vaccine Revenue Share by Type (2016-2021)

Table 106. Global Covid-19 Vaccine Revenue Forecast by Type (2021-2026)

Table 107. Global Covid-19 Vaccine Revenue by Application (2016-2021)

Table 108. Global Covid-19 Vaccine Revenue Forecast by Application (2021-2026)

Table 109. North America Covid-19 Vaccine Revenue by Type (2016-2021) & (USD Million)

Table 110. North America Covid-19 Vaccine Revenue by Type (2021-2026) & (USD Million)

Table 111. North America Covid-19 Vaccine Revenue by Application (2016-2021) & (USD Million)

Table 112. North America Covid-19 Vaccine Revenue by Application (2021-2026) & (USD Million)

Table 113. North America Covid-19 Vaccine Revenue by Country (2016-2021) & (USD Million)

Table 114. North America Covid-19 Vaccine Revenue by Country (2021-2026) & (USD Million)

Table 115. Europe Covid-19 Vaccine Revenue by Type (2016-2021) & (USD Million)

Table 116. Europe Covid-19 Vaccine Revenue by Type (2021-2026) & (USD Million)

Table 117. Europe Covid-19 Vaccine Revenue by Application (2016-2021) & (USD Million)

Table 118. Europe Covid-19 Vaccine Revenue by Application (2021-2026) & (USD Million)

Table 119. Europe Covid-19 Vaccine Revenue by Country (2016-2021) & (USD Million)

Table 120. Europe Covid-19 Vaccine Revenue by Country (2021-2026) & (USD Million)

Table 121. Asia-Pacific Covid-19 Vaccine Revenue by Type (2016-2021) & (USD Million)

Table 122. Asia-Pacific Covid-19 Vaccine Revenue by Type (2021-2026) & (USD Million)

Table 123. Asia-Pacific Covid-19 Vaccine Revenue by Application (2016-2021) & (USD Million)

Table 124. Asia-Pacific Covid-19 Vaccine Revenue by Application (2021-2026) & (USD Million)

Table 125. Asia-Pacific Covid-19 Vaccine Revenue by Region (2016-2021) & (USD Million)

Table 126. Asia-Pacific Covid-19 Vaccine Revenue by Region (2021-2026) & (USD Million)

Table 127. South America Covid-19 Vaccine Revenue by Type (2016-2021) & (USD Million)

Table 128. South America Covid-19 Vaccine Revenue by Type (2021-2026) & (USD Million)

Table 129. South America Covid-19 Vaccine Revenue by Application (2016-2021) & (USD Million)

Table 130. South America Covid-19 Vaccine Revenue by Application (2021-2026) & (USD Million)

Table 131. South America Covid-19 Vaccine Revenue by Country (2016-2021) & (USD Million)

Table 132. South America Covid-19 Vaccine Revenue by Country (2021-2026) & (USD Million)

Table 133. Middle East & Africa Covid-19 Vaccine Revenue by Type (2016-2021) & (USD Million)

Table 134. Middle East & Africa Covid-19 Vaccine Revenue by Type (2021-2026) & (USD Million)

Table 135. Middle East & Africa Covid-19 Vaccine Revenue by Application (2016-2021) & (USD Million)

Table 136. Middle East & Africa Covid-19 Vaccine Revenue by Application (2021-2026) & (USD Million)

Table 137. Middle East & Africa Covid-19 Vaccine Revenue by Country (2016-2021) & (USD Million)

Table 138. Middle East & Africa Covid-19 Vaccine Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Covid-19 Vaccine Picture

Figure 2. Global Covid-19 Vaccine Revenue Market Share by Type in 2020

Figure 3. DNA

Figure 4. Live Attenuated Virus

Figure 5. NonReplicating Viral Vecto

Figure 6. Protein Subunit

Figure 7. RNA

Figure 8. Covid-19 Vaccine Revenue Market Share by Application in 2020

Figure 9. Treatment Picture

Figure 10. Prevention Picture

Figure 11. Global Covid-19 Vaccine Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 12. Global Covid-19 Vaccine Revenue and Forecast (2016-2026) & (USD Million)

Figure 13. Global Covid-19 Vaccine Revenue Market Share by Region (2016-2026)

Figure 14. Global Covid-19 Vaccine Revenue Market Share by Region in 2020

Figure 15. North America Covid-19 Vaccine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Europe Covid-19 Vaccine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Asia-Pacific Covid-19 Vaccine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. South America Covid-19 Vaccine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Middle East and Africa Covid-19 Vaccine Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Covid-19 Vaccine Market Drivers

Figure 21. Covid-19 Vaccine Market Restraints

Figure 22. Covid-19 Vaccine Market Trends

Figure 23. Inovio Pharmaceuticals Recent Developments and Future Plans

Figure 24. Takis Biotech (Evvivax) Recent Developments and Future Plans

Figure 25. Zydus Cadila Recent Developments and Future Plans

Figure 26. Codagenix, Inc. Recent Developments and Future Plans

Figure 27. GeoVax, Inc. Recent Developments and Future Plans

Figure 28. Bravovax Recent Developments and Future Plans

Figure 29. Janssen Pharmaceutical Companies Recent Developments and Future Plans

Figure 30. Altimmune Recent Developments and Future Plans

Figure 31. Vaxart Recent Developments and Future Plans

Figure 32. CanSino Biologics Recent Developments and Future Plans

Figure 33. ExpreS2ion Biotechnologies ApS Recent Developments and Future Plans

Figure 34. Clover Biopharmaceuticals Recent Developments and Future Plans

Figure 35. GSK Recent Developments and Future Plans

Figure 36. Vaxil Bio Ltd. Recent Developments and Future Plans

Figure 37. Generex Recent Developments and Future Plans

Figure 38. Novavax, Inc. Recent Developments and Future Plans

Figure 39. Sanofi Pasteur Recent Developments and Future Plans

Figure 40. Baylor Recent Developments and Future Plans

Figure 41. iBio, Inc. Recent Developments and Future Plans

Figure 42. Zydus Cadila Recent Developments and Future Plans

Figure 43. Moderna, Inc. Recent Developments and Future Plans

Figure 44. Curevac Recent Developments and Future Plans

Figure 45. ImmunoPrecise Recent Developments and Future Plans

Figure 46. Global Covid-19 Vaccine Revenue Share by Players in 2020

Figure 47. Covid-19 Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 48. Global Top 3 Players Covid-19 Vaccine Revenue Market Share in 2020

Figure 49. Global Top 10 Players Covid-19 Vaccine Revenue Market Share in 2020

Figure 50. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 51. Global Covid-19 Vaccine Revenue Share by Type in 2020

Figure 52. Global Covid-19 Vaccine Market Share Forecast by Type (2021-2026)

Figure 53. Global Covid-19 Vaccine Revenue Share by Application in 2020

Figure 54. Global Covid-19 Vaccine Market Share Forecast by Application (2021-2026)

Figure 55. North America Covid-19 Vaccine Sales Market Share by Type (2016-2026)

Figure 56. North America Covid-19 Vaccine Sales Market Share by Application (2016-2026)

Figure 57. North America Covid-19 Vaccine Revenue Market Share by Country (2016-2026)

Figure 58. United States Covid-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Canada Covid-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Mexico Covid-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Europe Covid-19 Vaccine Sales Market Share by Type (2016-2026)

Figure 62. Europe Covid-19 Vaccine Sales Market Share by Application (2016-2026)

Figure 63. Europe Covid-19 Vaccine Revenue Market Share by Country (2016-2026)

Figure 64. Germany Covid-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. France Covid-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. United Kingdom Covid-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Russia Covid-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Italy Covid-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Asia-Pacific Covid-19 Vaccine Sales Market Share by Type (2016-2026)

Figure 70. Asia-Pacific Covid-19 Vaccine Sales Market Share by Application (2016-2026)

Figure 71. Asia-Pacific Covid-19 Vaccine Revenue Market Share by Region (2016-2026)

Figure 72. China Covid-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Japan Covid-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. South Korea Covid-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. India Covid-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Southeast Asia Covid-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Australia Covid-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. South America Covid-19 Vaccine Sales Market Share by Type (2016-2026)

Figure 79. South America Covid-19 Vaccine Sales Market Share by Application (2016-2026)

Figure 80. South America Covid-19 Vaccine Revenue Market Share by Country (2016-2026)

Figure 81. Brazil Covid-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Argentina Covid-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. Middle East and Africa Covid-19 Vaccine Sales Market Share by Type (2016-2026)

Figure 84. Middle East and Africa Covid-19 Vaccine Sales Market Share by Application (2016-2026)

Figure 85. Middle East and Africa Covid-19 Vaccine Revenue Market Share by Country (2016-2026)

Figure 86. Turkey Covid-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 87. Saudi Arabia Covid-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 88. UAE Covid-19 Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 89. Methodology

Figure 90. Research Process and Data Source